Lyra Therapeutics, Inc. — Form D

Lyra Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-08. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
James GoldsteinDirectorBoston, MA
Robert LangerDirectorPittsburgh, PA
Guido NeelsDirectorTORONTO, A6
Bradford SmithDirectorOttawa, Ontario, Z4
Carmichael RobertsDirectorMALDEN, MA
Maria PalasisDirectorAustin, TX
Maria PalasisExecutive OfficerAustin, TX
Konstantin PoukalovDirectorMarlton, NJ
James R TobinDirectorMarlton, NJ
W. Bradford SmithDirectorWatertown, MA
Konstantin Ann PoukalovDirectorWatertown, MA
Maria Palasis, Ph.D.DirectorWatertown, MA
Maria Palasis, Ph.D.Executive OfficerWatertown, MA
Nancy Bradford Snyderman, M.D., FACSDirectorWatertown, MA
C. Ann MerrifieldDirectorWatertown, MA
Richard R Nieman, M.D.Executive OfficerWatertown, MA
Harlan Waksal, M.D.DirectorWatertown, MA
Harlan Waksal, M.D.Executive OfficerWatertown, MA
John R Bishop, Ph.D.Executive OfficerWatertown, MA
Jason CavalierExecutive OfficerWatertown, MA
Michael AltmanDirectorWatertown, MA
Edward AndersonDirectorWatertown, MA
George WhitesidesDirectorBedford, MA
Terrance McGuireDirectorCambridge, MA
Robert Richard, Ph.D.Executive OfficerWatertown, MA

Other filings by this issuer (12)

FiledFormOfferingSold
2023-06-09D$50.0M$50.0M
2022-04-26D$100.5M$100.5M
2020-01-27D$28.0M$28.0M
2016-11-28D$6.0M$6.0M
2013-04-12D$21.2M$18.0M
2012-10-30D$6.0M$5.1M
2011-09-08D$18.0M$12.0M
2010-08-12D$3.0M$3.0M
2010-05-18D$10.1M$10.1M
2010-03-19D$1.0M$1.0M
2010-01-20D$2.0M$2.0M
2009-04-14D$12.2M$8.2M

More